Dandy-Walker Syndrome - Symptoms, Causes, Treatment & Prevention

Overview

Dandy‑Walker syndrome (DWS) is a rare congenital brain malformation that involves the cerebellum (the part of the brain that coordinates movement) and the fluid‑filled spaces surrounding it. The hallmark features are:

• Enlargement of the fourth ventricle (a cavity that contains cerebrospinal fluid – CSF)
• Partial or complete absence of the cerebellar vermis (the central portion that connects the two cerebellar hemispheres)
• Enlargement of the posterior (back) part of the skull (posterior fossa)

The condition is named after Walter Dandy and Arthur Earl Walker, who first described it in the 1940s.

Who it affects

DWS occurs in both males and females, but some series suggest a slight male predominance (about 55 % male). It is present at birth and therefore considered a developmental disorder.

Prevalence

Worldwide estimates range from 1 in 25,000 to 1 in 35,000 live births (≈0.003–0.004 % of the population) ¹. Because many infants have mild, undiagnosed cases, the true frequency may be slightly higher.

Symptoms

Symptoms can vary widely depending on the size of the cystic enlargement, associated brain abnormalities, and whether hydro­hydro­phalic pressure builds up. Below is a comprehensive list with brief explanations.

• Headache – Often worsens when lying down or during coughing, suggesting increased intracranial pressure.
• Vomiting – Usually non‑bilious and may be projectile; frequently occurs after meals.
• Increasing head circumference (in infants) – The skull expands to accommodate excess CSF.
• Developmental delay – Delayed motor milestones (rolling, sitting, walking) and speech.
• Ataxia – Uncoordinated gait or difficulty with fine motor tasks such as writing.
• Unsteady balance – Frequent falls or a broad-based walking pattern.
• Seizures – Generalized or focal; reported in up to 30 % of patients ².
• Hydrocephalus signs – Sunsetting eyes (downward gaze), irritability, or lethargy in infants.
• Vision problems – Nystagmus (involuntary eye movements) or strabismus.
• Learning difficulties – Attention deficits, problems with memory or problem‑solving.
• Behavioral issues – Autism‑spectrum traits or mood swings in some children.
• Facial or skeletal anomalies – Sometimes present if DWS is part of a broader syndrome (e.g., Meckel‑Gruber syndrome).

Causes and Risk Factors

Dandy‑Walker syndrome is not caused by a single gene; rather, it results from disruption of normal cerebellar development between the 4th and 8th weeks of gestation. Known contributors include:

Genetic factors

• Chromosomal abnormalities – Trisomy 13, trisomy 18, and Turner syndrome have been reported in association with DWS ³.
• Single‑gene mutations – Rare mutations in genes such as FOXC1 and VHL can predispose to posterior fossa malformations.

Environmental exposures

• Maternal infections – Rubella, cytomegalovirus, or toxoplasmosis during early pregnancy increase risk.
• Teratogenic substances – Alcohol, certain antiepileptic drugs (e.g., valproic acid), and retinoic acid have been implicated.
• Maternal diabetes – Uncontrolled hyperglycemia in the first trimester is a recognized risk factor for many neural‑tube defects.

Other risk factors

• Family history of posterior fossa malformations (though most cases are sporadic).
• Multiple gestation pregnancies (twins, triplets), possibly due to altered intra‑uterine dynamics.

Diagnosis

Because many newborns are asymptomatic, DWS is often discovered incidentally during prenatal ultrasound or post‑natal imaging for unrelated concerns.

Imaging studies

• Prenatal ultrasound – Detects an enlarged posterior fossa and cystic structure as early as 18–20 weeks gestation.
• Fetal MRI – Provides more detailed anatomy and helps differentiate DWS from other posterior fossa cysts.
• Post‑natal MRI (preferred) – Shows vermian hypoplasia, fourth‑ventricle dilation, and posterior fossa enlargement. MRI is the gold standard for surgical planning.
• CT scan – Useful when MRI is unavailable or when rapid assessment for acute hydrocephalus is needed.

Additional evaluations

• Neurological exam – Assesses motor coordination, reflexes, and cranial nerve function.
• Neuro‑ophthalmologic testing – Checks for nystagmus, strabismus, or optic nerve abnormalities.
• Genetic testing – Chromosomal microarray or targeted gene panels if a syndromic association is suspected.
• Hydrocephalus monitoring – Serial head‑circumference measurements in infants and regular ultrasound of the ventricles.

Treatment Options

Management is individualized and often involves a multidisciplinary team (neurology, neurosurgery, genetics, physiotherapy, and psychology). The primary goals are to control hydrocephalus, improve neurological function, and support development.

Medical management

• Acetazolamide – Occasionally used short‑term to reduce CSF production while awaiting surgery.
• Antiepileptic drugs (AEDs) – Tailored to seizure type; levetiracetam and valproic acid are common first‑line choices.
• Physical and occupational therapy – Initiated early to address ataxia, muscle tone, and fine‑motor skills.

Surgical interventions

1. Ventriculoperitoneal (VP) shunt – Diverts excess CSF from the ventricles to the abdominal cavity. Indicated when hydrocephalus causes progressive symptoms.
2. Cystoperitoneal shunt – Specifically relieves pressure from the posterior fossa cyst when it contributes to obstruction.
3. Endoscopic third ventriculostomy (ETV) – Creates a bypass channel for CSF flow; preferred in children where shunt dependency is a concern.
4. Posterior fossa decompression – Rarely needed but may be considered if the enlarged posterior fossa compresses the brainstem.

Post‑operative follow‑up includes regular imaging to monitor shunt function and cyst size.

Lifestyle & supportive measures

• Ensuring adequate nutrition and calcium/vitamin D intake for bone health (important if steroids are used for seizures).
• Sleep hygiene and avoiding sudden head‑position changes that could transiently raise intracranial pressure.
• Use of assistive devices (e.g., gait trainers or adaptive utensils) as needed.
• Psychological support for the child and family, including counseling and support groups.

Living with Dandy‑Walker Syndrome

While DWS is a lifelong condition, many individuals lead productive lives with the right care plan.

Daily management tips

• Regular medical appointments – At least twice a year with a pediatric neurologist or adult neurologist, plus annual MRI if shunts are present.
• Monitor head size (infants) – A rapid increase (>2 cm in a month) warrants urgent evaluation.
• Medication adherence – Keep a written schedule; use pill organizers or alarms.
• Educate caregivers and teachers – Provide an individualized education plan (IEP) that addresses motor and learning challenges.
• Stay active – Low‑impact exercises (swimming, bicycle riding with support) improve balance and cardiovascular health.
• Safety precautions – Use helmets when biking, install grab bars in bathrooms, and keep the home free of tripping hazards.

Transition to adulthood

Adolescents should begin discussions about driving, employment, and independent living. Vocational therapy and community resources can facilitate a smoother transition.

Prevention

Because most cases are sporadic, absolute prevention is not possible. However, reducing known risk factors can lower the odds of DWS or related posterior fossa malformations.

• Pre‑conception care – Optimize maternal health: control diabetes, maintain a healthy weight, and discuss medication safety with a physician.
• Vaccination – Immunize against rubella, varicella, and other teratogenic infections before pregnancy (CDC ⁴).
• Avoid alcohol and teratogenic drugs – No amount of alcohol is considered safe during pregnancy.
• Folic acid supplementation – 400–800 µg daily reduces risk of neural‑tube defects, which share embryologic pathways with DWS.
• Early prenatal screening – Routine ultrasound and, when indicated, fetal MRI can identify anomalies early, allowing for informed decision‑making.

Complications

If untreated or poorly managed, Dandy‑Walker syndrome can lead to serious health problems.

• Progressive hydrocephalus – Can cause permanent brain damage, visual loss, or cognitive decline.
• Recurrent shunt malfunction – Infections, blockage, or over‑drainage may require revision surgery.
• Seizure disorders – Uncontrolled seizures increase risk of injury and affect learning.
• Spasticity or permanent ataxia – May limit mobility and independence.
• Psychiatric comorbidities – Depression, anxiety, or behavioral disorders are reported in up to 20 % of adolescents.
• Secondary scoliosis – Chronic imbalance can lead to spinal curvature, especially in children who walk with a wide base.

When to Seek Emergency Care

References

1. Mayo Clinic. “Dandy‑Walker malformation.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/dandy-walker-malformation
2. Cleveland Clinic. “Hydrocephalus & Dandy‑Walker Complex.” 2024. https://my.clevelandclinic.org/health/diseases/16691-dandy-walker-malformation
3. NIH National Institute of Neurological Disorders and Stroke. “Dandy‑Walker Malformation Fact Sheet.” 2022. https://www.ninds.nih.gov/Disorders/All-Disorders/Dandy-Walker-Malformation-Information-Page
4. CDC. “Prenatal Care: Vaccines for Pregnant Women.” 2023. https://www.cdc.gov/pregnancy/vaccines.html
5. World Health Organization. “Folic Acid Supplementation.” 2021. https://www.who.int/news-room/fact-sheets/detail/folic-acid
6. Shen J, et al. “Genetic landscape of Dandy‑Walker malformation.” *Journal of Medical Genetics*, 2020;57(10):674‑682. DOI:10.1136/jmedgenet-2020-107123